C12Y 103/05004
Fumarate reductase
Official title: Fumarate reductase (menaquinone) (1.3.5.4)
C12Y103/05004 (Fumarate reductase) appears on 3 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 4
- Assignees
- 6
- Inventors
- 12
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 2 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Genetically modified microorganism for production of aspartic acid and downstream metabolites from aspartic acid as target substance, and method for producing target substance using same14 Apr 2026US 12,600,991 B2Green Earth Institute Co., Ltd.
- Construction and application of engineered strain of Escherichia coli for producing malic acid by fixing CO230 Jul 2024US 12,049,661 B2Jiangnan University
- Butanol expression cassette, recombinant plasmid and butanol production related gene expression method28 Apr 2020US 10,633,677 B2Chang Chun Petrochemical Co., Ltd.
- Genetically modified microorganism and method for producing target substance using same9 Jun 2022US 2022/0177924 A1Green Earth Institute Co., Ltd.
- Construction and Application of Engineered Strain of Escherichia Coli for Producing Malic Acid by Fixing CO26 Jan 2022US 2022/0002766 A1Jiangnan University
- Butanol expression cassette, recombinant plasmid and butanol production related gene expression method28 Jun 2018US 2018/0179556 A1Chang Chun Petrochemical Co., Ltd.
- Bioproduct formation from a plasmid addiction system in the absence of co-inducers and antibiotics26 Oct 2017US 2017/0306337 A1Ohio State Innovation Foundation
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.